Study shows J&J Covid vaccine may be less effective against delta variant

A new study suggests that the one-shot Johnson & Johnson vaccine may be less effective against the delta variant and that the people who’ve received it may need a booster. The CDC does not recommend that and the study is facing backlash because it was not peer-reviewed and had a small sample size.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting